FAQ

Epoetin Alfa

Known as: Erythropoietin, 1-165-Erythropoietin (human clone lambdaHEPOFL13 protein moiety), glycoform alpha, EPO 
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine human erythropoietin (EPO). Produced primarily… (More)

Topic mentions per year

Topic mentions per year

1957-2018
05010015019572017

Related topics

Related topics

26 relations
AnemiaB-Cell ActivationDrug AllergyEPO protein, human
(More)

Narrower (5)

BinocritEpogenEprexHX575
(More)

Broader (2)

HematinicsRecombinant Erythropoietin

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Epoetin Alfa
Hypertensive disease
Drug Allergy
Anemia
physiological aspects
agonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Efficacy and safety of epoetin alfa in critically ill patients.
BACKGROUND Anemia, which is common in the critically ill, is often treated with red-cell transfusions, which are associated with… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Correction of anemia with epoetin alfa in chronic kidney disease.
BACKGROUND Anemia, a common complication of chronic kidney disease, usually develops as a consequence of erythropoietin… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Pure red-cell aplasia and epoetin therapy.
BACKGROUND Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.
BACKGROUND & AIMS Combination therapy with interferon alpha (IFN-alpha) and ribavirin (RBV) or pegylated IFN-alpha (PEG-IFN-alpha… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
PURPOSE This randomized, double-blind, placebo-controlled clinical trial assessed the effects of epoetin alfa on transfusion… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
PURPOSE To prospectively evaluate the effectiveness, safety, and clinical benefits of once-weekly epoetin alfa therapy as an… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients.
Novel erythropoiesis stimulating protein (NESP) is a hyperglycosylated analogue of recombinant human erythropoietin (Epoetin… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.
PURPOSE To evaluate prospectively the effectiveness of epoetin alfa as an adjunct to chemotherapy in patients with cancer based… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
PURPOSE To study the impact of Procrit (epoetin alfa; Amgen Inc, Thousand Oaks, CA) on quality of life, transfusion requirements… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta.
Different recombinant human erythropoietin products have been developed. Although they appear to have similar pharmacokinetics… (More)
Is this relevant?